Viewing Study NCT03726333

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-01-05 @ 11:44 PM
Study NCT ID: NCT03726333
Status: TERMINATED
Last Update Posted: 2024-06-21
First Post: 2018-09-24
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Hepatic Impairment Study for Lorlatinib in Cancer Patients
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Cancers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hepatic impairment View
None lorlatinib View
None cancer View
None pharmacokinetic View
None Lung cancer View